Given the scarcity of comprehensive data on Huntington's disease in many Asian and African countries, it is more effective to focus on specific regions where there is a significant concentration of available data.
Objective
This study decided to evaluate the epidemiology and features of Huntington's disease in countries of the Middle East, North Africa, and South Asia (MENASA) regions.
Methods
In this meta-analysis, the limited maximum likelihood (REML) approach was applied to the estimated point prevalence mentioned in original studies of each MENASA country. Additionally, research on Huntington's disease characteristics in each nation was utilized to give a general picture of the disease's status in those nations.
Results
The pooled point prevalence estimation of the prevalence studies was 8.64 per 100,000 (95% CI, −0.04–17.33; I2 = 100%). Among 14 cohort and cross-sectional studies on individuals with Huntington's disease in the MENASA region, 5.61% of the patients had juvenile-onset Huntington's disease, and 2.3% had late-onset Huntington's disease. In addition, 68.58%, 17.82%, and 45.17% of the individuals were reported with motor symptoms at the onset, abnormal cognitive assessment scores, and degrees of psychological disturbance, respectively. The mean age at onset was 44.85 years, and the mean number of pathologic CAG repeats was 45.46.
Conclusions
Notable differences in the frequency of symptoms of onset and pooled prevalence of HD in the MENASA region probably address a serious lack of sufficient information. The results would help clinicians and governments develop public health strategies, and further research could be conducted on these results.
JhavarKRPalPKNagarajMS, et al.A clinical and genetic profile of 17 patients with Huntington’s disease seen in Southern India. Mov Disord2011; 26: S62.
2.
RatnaNPasupulatiSLNadellaRK, et al.Complexities in genetic counseling and testing of Huntington’s Disease: a perspective from India. Neurol India2022; 70: 2141–2144.
3.
RossCATabriziSJ. Huntington’s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol2011; 10: 83–98.
4.
LobnaANajehSFadwaC, et al.Psychiatric manifestations revealing Huntington’s disease: concerning one case. Inf Psychiatr2018; 94: 211–215.
5.
HasnainNBinATShafautR, et al.Association between sex and Huntington’s disease: an updated review on symptomatology and prognosis of neurodegenerative disorders. Wien Med Wochenschr2024; 174: 87–94.
6.
MurgodUASaleemQAnandA, et al.A clinical study of patients with genetically confirmed Huntington’s disease from India. J Neurol Sci2001; 190: 73–78.
7.
WarbySCVisscherHCollinsJA, et al.HTT Haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia. Eur J Hum Genet2011; 19: 561–566.
8.
Medina EscobarAPringsheimTGautreauS, et al.Epidemiology of Huntington’s disease in Latin America: a systematic review and meta-analysis. Mov Disord2024; 39: 1907–1921.
9.
PapannaBLazzariCRabottiniM. Huntington’s disease prevalence in Asia: a systematic review and meta-analysis. Riv Psichiatr2024; 59: 4–12.
10.
MedinaAMahjoubYShaverL, et al.Prevalence and incidence of Huntington’s disease: an updated systematic review and meta-analysis. Mov Disord2022; 37: 2327–2335.
11.
PapannaBLazzariCRabottiniM. The Prevalence of Huntington disease in Asia highlights needs in clinical, genetic and instrumental diagnosis: a systematic review and meta-analysis. Psychiatr Danub2022; 34: 13–23.
12.
KhalilHChahineLMSiddiquiJ, et al.Parkinson’s disease in the Middle East, North Africa, and South Asia: consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East. J Parkinsons Dis2020; 10: 729–741.
13.
RadhakrishnanDGeorgeJFaruqM, et al.Characteristics of Huntington disease in a north Indian cohort. Mov Disord2023; 38: S405–S406.
14.
NehdiHNabliFSaiedZ, et al.Clinical and molecular features of Tunisian patients with Biallelic mutations in Huntington’s disease. Mov Disord2023; 38: S405–S405.
15.
BarerYRibalovRYaariA, et al.Healthcare utilization, costs, and epidemiology of Huntington’s disease in Israel. Clin Park Relat Disord2023; 9: 100208.
MunnZMoolaSRiitanoD, et al.The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. Int J Health Policy Manag2014; 3: 123.
18.
BelghuithSSakkaSFarhatN, et al.Huntington’s disease: neuropsychiatric presentation of a Tunisian cohort. Eur J Neurol2019; 26: 451.
19.
NehdiHSaiedZNabliF, et al.Huntington’s disease patients with intermediate allele in Tunisia. Mov Disord2023; 38: S398–S399.
20.
ThotaSMChanKLPradhanSS, et al.Multimodal imaging and visual evoked potentials reveal key structural and functional features that distinguish symptomatic from presymptomatic Huntington’s disease brain. Neurol India2021; 69: 1247–1258.
21.
BasuPGungulyPKBasuD, et al.Molecular diagnosis of myotonic dystrophy and Huntington’s disease from Calcutta, India. Neurol India1998; 46: 199–203.
22.
De SilvaRGonawalaLGamageR, et al.J13 the role of natural products on Huntington disease: a Sri Lankan perspective. J Neurol Neurosurg Psychiatry2014; 85: A69.
23.
SumathipalaDSJayasekaraRWDissanayakeVHW. Clinical and genetic features of Huntington disease in Sri Lanka. BMC Neurol2013; 13: 191.
24.
SquitieriFAl-HajriHAl-HajriM, et al.Huntington’s disease in the Arabic peninsula: a report from the Sultanate of Oman. Neurotherapeutics2018; 15: 1199.
25.
ScrimgeourEMKoulRLChandPR, et al.Juvenile onset Huntington’s disease in an Omani child with asymptomatic, at risk parents. J Med Genet1997; 34: 701.
26.
SquitieriFAl-HarasiSPardoD, et al.K13 First Middle Eastern focus on research and assistance on Huntington disease in Oman. J Neurol Neurosurg Psychiatry2014; 85: A83.
27.
PramanikSBasuPGangopadhayaPK, et al.Analysis of CAG and CCG repeats in Huntingtin gene among HD patients and normal populations of India. Eur J Hum Genet2000; 8: 678–682.
28.
RatnaNKambleNLVenkateshSD, et al.Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease. BMC Neurol2020; 20: 87.
29.
RatnaNJainSVargheseM, et al.F16 Clinical profile of juvenile Huntington disease: an Indian cohort. J Neurol Neurosurg Psychiatry2018; 89: A45.2–A4A45.
30.
ShiwachRSLindenbaumRH. Prevalence of Huntington’s disease among UK immigrants from the Indian subcontinent. Br J Psychiatry1990; 157: 598–599.
31.
HussainZMukherjeeAGangulyG, et al.Clinical profile of genetically proven Huntington’s disease patients from Eastern India. Ann Indian Acad Neurol2020; 23: 195–200.
32.
LenkaAKambleNLSowmyaV, et al.Determinants of onset of Huntington’s disease with behavioral symptoms: insight from 92 patients. J Huntingtons Dis2015; 4: 319–324.
33.
Shekari KhanianiMAobPRanjouriM, et al.Molecular analysis and prevalence of Huntington disease in northwestern Iran. Turkish J Med Sci2017; 47: 1880–1884.
34.
KandilMRTohamySAFattahMA, et al.Prevalence of chorea, dystonia and athetosis in Assiut, Egypt: a clinical and epidemiological study. Neuroepidemiology1994; 13: 202–210.
35.
RibalovRYaariAChodickG, et al.PND67 The real-world epidemiology and treatment patterns of Huntington’s disease in Israel. Value Health2020; 23: S635.
36.
MelamedOBeharDMBramC, et al.Founder mutation for Huntington disease in Caucasus Jews. Clin Genet2015; 87: 167–172.
37.
WijekoonNGonawalaLRatnayakeP, et al.Gene therapy for selected neuromuscular and trinucleotide repeat disorders - An insight to subsume South Asia for multicenter clinical trials. IBRO Neurosci Reports2023; 14: 146–153.
38.
SamaranayakeNDissanayakaPGunarathnaI, et al.What we fail to see in neuro-genetic diseases: a bird’s eye view from the developing world. Ann Neurosci2020; 27: 91–97.
39.
SquitieriFMaffiSAl HarasiS, et al.Incidence and prevalence of Huntington disease (HD) in the Sultanate of Oman: the first Middle East post- HTT service-based study. J Neurol Neurosurg Psychiatry2020; 91: 1359–1360.
40.
AtaçFBElibolBSchaeferF. The genetic analysis of Turkish patients with Huntington’s disease. Acta Neurol Scand1999; 100: 195–198.
41.
KaradagYSBECYukselRN. Huntington’s disease in Turkey: genetic counseling, clinical features, and outcome. Neurol Res2021; 43: 381–386.
42.
KaradagYAkbostanciMAHanagasiH, et al.Huntington’s disease in Turkey: a bird’s eye review of the literature. Mov Disord2018; 33: S315.
43.
OosterlooMTouzeAByrneLM, et al.Clinical review of juvenile Huntington’s disease. J Huntingtons Dis2024; 13: 149–161.
44.
QuarrellOO’DonovanKLBandmannO, et al.The prevalence of juvenile Huntington’s disease: a review of the literature and meta-analysis. PLoS Curr2012; 4: e4f8606b742ef3.
45.
FurbyHMooreSNordstroemA-L, et al.Comorbidities and clinical outcomes in adult- and juvenile-onset Huntington’s disease: a study of linked Swedish National Registries (2002–2019). J Neurol2023; 270: 864–876.
46.
ChagantiSSMcCuskerEALoyCT. What do we know about late onset Huntington’s disease?J Huntingtons Dis2017; 6: 95–103.
47.
OosterlooMBijlsmaEKvan KuijkSM, et al.Clinical and genetic characteristics of late-onset Huntington’s disease. Parkinsonism Relat Disord2019; 61: 101–105.
48.
VolpiETerenziFBagnoliS, et al.Late-onset Huntington disease: an Italian cohort. J Clin Neurosci2021; 86: 58–63.
49.
CapiluppiERomanoLReboraP, et al.Late-onset Huntington’s disease with 40-42 CAG expansion. Neurol Sci2020; 41: 869–876.
50.
ScrimgeourEMTahoonSAZawawiTH. Huntington’s disease in two unrelated Arab kindreds and in an Afghani family resident in Saudi Arabia. J Med Genet1994; 31: 819–820.
51.
BohlegaSMcLeanDKawiA, , et al.Huntington’s disease: report on four Saudi families. Saudi Med J1996; 17: 456–460.
52.
RoyBBRaoKPWardCD. Huntington’s disease in an Asian-Indian male - A case report and discussion. Eur Psychiatry2010; 25: 516.
53.
JhaMKambleNLenkaA, et al.Sleep disturbances in patients with Huntington’s disease: a questionnaire-based study. Ann Mov Disord2019; 2: 9–14.
54.
SejilIBecheikhDBen DjebaraM, et al.Huntington’s disease and forensic acts. Rev Med Leg2012; 3: 179–182.
55.
YaluǧIÖztenETufanAE. Psychiatric findings in a patient with Huntington’s chorea: case report. Turkiye Klin J Med Sci2006; 26: 569–574.
56.
BhattRVyasHDabhiR, et al.F04 Genotype-phenotype correlation of huntingtin cag repeat expansion and associated symptoms in a large Indian family carrying Huntington’s disease mutation. J Neurol Neurosurg Psychiatry2018; 89: A41.3–A4A42.
57.
Das BhowmikARangaswamaiahSSrinivasG, et al.Molecular genetic analysis of trinucleotide repeat disorders (TRDs) in Indian population and application of repeat primed PCR. Eur J Med Genet2015; 58: 160–167.
58.
SaleemQRoySMurgoodU, et al.Molecular analysis of Huntington’s disease and linked polymorphisms in the Indian population. Acta Neurol Scand2003; 108: 281–286.
59.
Devatha VenkateshSVargheseMYadavR, et al.C10 Haplotype structure analysis of Indian Huntington’s disease patients at HTT gene locus. J Neurol Neurosurg Psychiatry2022; 93: A19.2–A1A19.
60.
Hmida-Ben BrahimDChourabiMBen AmorS, et al.Modulation at age of onset in Tunisian Huntington disease patients: implication of new modifier genes. Genet Res Int2014; 2014: 210418.
61.
ZitserJThalerAInbarN, et al.Two ethnic clusters with Huntington disease in Israel: the case of Mountain Jews and Karaites. Neurodegener Dis2017; 17: 281–285.
62.
PringsheimTWiltshireKDayL, et al.The incidence and prevalence of Huntington’s disease: a systematic review and meta-analysis. Mov Disord2012; 27: 1083–1091.
63.
HaydenMRMacGregorJMBeightonPH. The prevalence of Huntington’s chorea in South Africa. S Afr Med J1980; 58: 193–196.
64.
PetraccaMDi TellaSSolitoM, et al.Clinical and genetic characteristics of late-onset Huntington’s disease in a large European cohort. Eur J Neurol2022; 29: 1940–1951.
65.
ThomasJ. Medical records and issues in negligence. Indian J Urol2009; 25: 384–388.
66.
TunaliNEAcar-HazerAErginel-UnaltunaN, et al.C04 The effects of GRIN gene variations on age at onset of Turkish Huntington’s disease patients. J Neurol Neurosurg Psychiatry2010; 81: A17.1–A1A17.
67.
ScrimgeourEM. Huntington disease (chorea) in the middle East. Sultan Qaboos Univ Med J2009; 9: 16–23.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
